Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of continuous fospropofol disodium infusion for sedation in adult ICU patients
CTR20250200Phase 2Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Jan 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fospropofol disodium in sedation, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Jan 2025; status: completed.
02
Drugs
fospropofol disodium
03
Conditions
sedation
Beyond the preview
Go deeper on CTR20250200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250200.